EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19

Giulia Marchetti, Roberta Rovito, Valeria Bono, Paola Bonara, Francesca Bai, Antonella d'Arminio Monforte

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.01.016 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Giulia Marchetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Regione Lombardia, Fondazione Cariplo, Fondazione Umberto Veronesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansRitonavirCOVID-19 Drug TreatmentAntiviral AgentsLactamsLeucineNitrilesProline

Substanzen

RitonavirAntiviral AgentsnirmatrelvirLactamsLeucineNitrilesProline

Autor:innen und Institutionen

  • Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy. Electronic address: giulia.marchetti@unimi.it.
  • Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Förderung

  • Regione Lombardia
  • Fondazione Cariplo
  • Fondazione Umberto Veronesi

Zitieren

APA

Marchetti, G., Rovito, R., Bono, V., Bonara, P., Bai, F., & Monforte, A. D. (2023). Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.01.016

Vancouver

Marchetti G, Rovito R, Bono V, Bonara P, Bai F, Monforte AD. Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.01.016

BibTeX
@article{Marchetti2023,
  author = {Marchetti, Giulia and Rovito, Roberta and Bono, Valeria and Bonara, Paola and Bai, Francesca and Monforte, Antonella d'Arminio},
  title = {Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.01.016}
}
Kostenlos starten →